StockData
LeonaBio, Inc. logo

LeonaBio, Inc. (LONA) stock

LONANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$2.46−0.19 (-7.17%)

Close on Nov 19, 2026Market cap $23.18MP/E –Yield –

LeonaBio operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

LeonaBio's operating income for the twelve months ending Jun 30, 2026 was -$122.11M. For fiscal 2025 it was -$102.27M. The highest annual figure on record is -$5.45M in fiscal 2019.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$102.27M–
FY2024Dec 31, 2024-$100.90M–
FY2023Dec 31, 2023-$125.47M–
FY2022Dec 31, 2022-$104.02M–
FY2021Dec 31, 2021-$64.02M–
FY2020Dec 31, 2020-$20.00M–
FY2019Dec 31, 2019-$5.45M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$19.45M–
Q1 FY2026Mar 31, 2026-$17.21M–
Q4 FY2025Dec 31, 2025-$78.57M–
Q3 FY2025Sep 30, 2025-$6.87M–
Q2 FY2025Jun 30, 2025-$7.29M–
Q1 FY2025Mar 31, 2025-$9.54M–
Q4 FY2024Dec 31, 2024-$15.57M–
Q3 FY2024Sep 30, 2024-$29.62M–
Q2 FY2024Jun 30, 2024-$28.03M–
Q1 FY2024Mar 31, 2024-$27.69M–
Q4 FY2023Dec 31, 2023-$29.01M–
Q3 FY2023Sep 30, 2023-$35.04M–
Q2 FY2023Jun 30, 2023-$31.64M–
Q1 FY2023Mar 31, 2023-$29.77M–
Q4 FY2022Dec 31, 2022-$32.93M–
Q3 FY2022Sep 30, 2022-$24.13M–
Q2 FY2022Jun 30, 2022-$23.57M–
Q1 FY2022Mar 31, 2022-$23.39M–
Q4 FY2021Dec 31, 2021-$18.78M–
Q3 FY2021Sep 30, 2021-$17.83M–
Q2 FY2021Jun 30, 2021-$16.64M–
Q1 FY2021Mar 31, 2021-$10.78M–
Q4 FY2020Dec 31, 2020-$9.08M–
Q3 FY2020Sep 30, 2020-$7.40M–
Q2 FY2020Jun 30, 2020-$2.25M–
Q1 FY2020Mar 31, 2020-$1.27M–
Q4 FY2019Dec 31, 2019-$1.12M–
Q3 FY2019Sep 30, 2019-$1.54M–

More LeonaBio figures

See a number that looks wrong?